Gapping down
In reaction to disappointing earnings/guidance:
- SWIR -23.9%, FOSL -16.6%, NGD -13.7%, RYAM -12.8%, LPI -11.6%, BKD -10.7%, CTL -10.2%, IIIV -8.9%, NTAP -7.9%, MMLP -7.6%, FNF -6.9%, SIX -6.4%, BCOV -5.8%, QTWO -5.6%, SKT -5.5%, POOL -4.7%, TPX -4.5%, AEG -4.4%, ASGN -4.3%, IFF -4.2%, EQM -4.2%, CRY -4.1%, PXD -3.8%, AIG -3.8%, TRU -3.8%, SPWR -3.7%, BWA -3.4%, AVP -3.4%, WLH -3.2%, KO -2.7%, WSO -2.6%, TSE -2.4%, CS -2.3%, NUS -2.2%, WMB -2% (also Targa Resources and Williams Cos (WMB) announce new NGL agreements and option for Mont Belvieu fractionation joint venture), MGM -1.9%, PS -1.9%, PPL -1.3%, ARI -1.1%
Other news:
- MTFB -77.2% (receives Complete Response Letter from the FDA regarding the New Drug Application for iclaprim for the treatment of acute bacterial skin and skin structure infections)
- INO -16.9% (prices offering of $65.0 mln aggregate principal amount of 6.50% convertible senior notes due 2024)
- XERS -6.1% (prices offering of 5.88 mln shares of common stock at $10.00 per share)
- HUBS -4.1% (commences underwritten public offering of 1.7 mln shares of common stock)
Analyst comments:
- ALGN -1.7% (downgraded to Neutral from Buy at UBS)
- CMA -1.1% (downgraded to Market Perform from Outperform at BMO Capital Markets)